Authors
Latest:
Resource Use Among Nonvalvular Atrial Fibrillation PatientsThis study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Trends Associated with Implementing and Lifting a Pregabalin Step Therapy PolicyThis study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.
Latest:
Keys to Creating a Healthier and Longer LifeDiscover nine overlapping eating habits and lifestyle practices that can help create a healthier, happier, and longer life.
Latest:
What’s Ahead? Pharmacy Technology Will Drive Patient CareThe pharmacist plays a critical role in supporting the care plan developed between the patient and the physician.
Latest:
Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial FibrillationThis study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
Latest:
Dasatinib Approved for Treatment of Certain Pediatric PatientsThe FDA has approved dasatinib (Sprycel, Briston-Myers Squibb) tablets in combination with chemotherapy for the treatment of pediatric patients ≥1 year of age with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).
Latest:
Vaccinating Adults Amid Crisis Poses ChallengesPharmacists can greatly contribute to herd immunity during this unprecedented health crisis.
Latest:
JNC 8 and Older Adults: A Review of the EvidenceNew Guideline for Blood Pressure Management in Older Patients
Latest:
Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature ReviewThe authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.
Latest:
Pulmonary Arterial Hypertension: Keeping Patients InformedArming patients with essential knowledge about pulmonary arterial hypertension empowers them to make informed decisions about their health.
Latest:
Double Dosing: Helping Patients Understand the Risks During Cold SeasonIt’s a good time to talk to patients about the potential risks of taking over-the- counter (OTC) cold and flu medication and other OTC or prescription analgesics and antipyretics concomitantly.
Latest:
Talking with Patients about Opioid Risks and SafetyOpen communication between patients and care providers--including pharmacists--is critical in ensuring the safe use of opioids.
Latest:
Innovations in EducationRoosevelt University College of Pharmacy offers a unique 3-year program with state-of-the-art facilities.
Latest:
New Combination Therapies for the Treatment of Chronic Lymphocytic LeukemiaPatients with CLL may have genetic mutations that predict response to different treatments.
Latest:
It's Time to Say Good-byeThank you all for your support and encouragement, but it is now time for me to put this part of my career in the past.
Latest:
Specialty Pharmacy Considerations for Oral Multiple Sclerosis TherapiesMultiple sclerosis treatment options have expanded dramatically over the past several years. In addition to subcutaneous and intravenous medications, there are now 3 disease-modifying oral therapies available in the United States.
Latest:
Effective Drug Therapy for EpilepsyUnderstanding the drug interactions associated with antiepileptic drugs can avoid complications.
Latest:
Challenges Continue for True Patient-Centered AccessAccess to oral chemotherapies is filled with challenges for providers and patients that can be significant, resulting in delayed therapy.
Latest:
A Multi-Pronged Approach to Addressing the Opioid EpidemicThe opioid epidemic in the United States is a critical public health issue that requires a multi-stakeholder, multi-pronged approach to mitigate its devastating outcomes.
Latest:
Working Outside the Dispensing Box: The Roles of the Medical Information Specialist and Medical Science LiaisonAs medical information specialists and medical science liaisons, pharmacists use their drug expertise and clinical skills to serve as information providers
